Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | LOCUS Repositório Institucional da UFV |
Texto Completo: | http://dx.doi.org/10.1017/S1431927617012363 http://www.locus.ufv.br/handle/123456789/22685 |
Resumo: | By using an experimental model of dexamethasone-induced osteoporosis we investigated the effects of different therapeutic schemes combining sodium alendronate (SA) and simvastatin on bone mineral and protein composition, microstructural and mechanical remodeling. Wistar rats were randomized into eight groups: G1: non-osteoporotic; G2: osteoporotic; G3, G4, and G5: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively); G6, G7, and G8: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively) + simvastatin (0.4, 0.6, and 1 mg/kg, respectively). Osteoporosis was induced by dexamethasone (7 mg/kg, i.m.) once a week for 5 weeks. All treatments were administered for 8 weeks. Dexamethasone increased serum levels of alkaline phosphatase, calcium, phosphorus, and urea, especially in non-treated animals, which showed severe osteoporosis. Dexamethasone also induced bone microstructural fragility and reduced mechanical resistance, which were associated with a marked depletion in mineral mass, collagenous and non-collagenous protein levels in cortical and cancellous bone. Although SA has attenuated osteoporosis severity, the effectiveness of drug therapy was enhanced combining alendronate and simvastatin. The restoration in serum parameters, organic and inorganic bone mass, and mechanical behavior showed a dose-dependent effect that was potentially related to the complementary mechanisms by which each drug acts to induce bone anabolism, accelerating tissue repair. |
id |
UFV_59e02d0c0abd857af381ea3d4407b41d |
---|---|
oai_identifier_str |
oai:locus.ufv.br:123456789/22685 |
network_acronym_str |
UFV |
network_name_str |
LOCUS Repositório Institucional da UFV |
repository_id_str |
2145 |
spelling |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosisBoneGlucocorticoidMicroanalysisPathologyScanning electron microscopyBy using an experimental model of dexamethasone-induced osteoporosis we investigated the effects of different therapeutic schemes combining sodium alendronate (SA) and simvastatin on bone mineral and protein composition, microstructural and mechanical remodeling. Wistar rats were randomized into eight groups: G1: non-osteoporotic; G2: osteoporotic; G3, G4, and G5: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively); G6, G7, and G8: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively) + simvastatin (0.4, 0.6, and 1 mg/kg, respectively). Osteoporosis was induced by dexamethasone (7 mg/kg, i.m.) once a week for 5 weeks. All treatments were administered for 8 weeks. Dexamethasone increased serum levels of alkaline phosphatase, calcium, phosphorus, and urea, especially in non-treated animals, which showed severe osteoporosis. Dexamethasone also induced bone microstructural fragility and reduced mechanical resistance, which were associated with a marked depletion in mineral mass, collagenous and non-collagenous protein levels in cortical and cancellous bone. Although SA has attenuated osteoporosis severity, the effectiveness of drug therapy was enhanced combining alendronate and simvastatin. The restoration in serum parameters, organic and inorganic bone mass, and mechanical behavior showed a dose-dependent effect that was potentially related to the complementary mechanisms by which each drug acts to induce bone anabolism, accelerating tissue repair.Microscopy and Microanalysis2018-12-04T12:36:46Z2018-12-04T12:36:46Z2017-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlepdfapplication/pdf1435-8115http://dx.doi.org/10.1017/S1431927617012363http://www.locus.ufv.br/handle/123456789/22685engVolume 23, Issue 5, Pages 989- 1001, October 2017Sequetto, Priscila L.Gonçalves, Reggiani V.Pinto, Aloísio S.Oliveira, Maria G. A.Maldonado, Izabel R. S. C.Oliveira, Tânia T.Novaes, Rômulo D.info:eu-repo/semantics/openAccessreponame:LOCUS Repositório Institucional da UFVinstname:Universidade Federal de Viçosa (UFV)instacron:UFV2024-07-12T07:50:21Zoai:locus.ufv.br:123456789/22685Repositório InstitucionalPUBhttps://www.locus.ufv.br/oai/requestfabiojreis@ufv.bropendoar:21452024-07-12T07:50:21LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)false |
dc.title.none.fl_str_mv |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis |
title |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis |
spellingShingle |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis Sequetto, Priscila L. Bone Glucocorticoid Microanalysis Pathology Scanning electron microscopy |
title_short |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis |
title_full |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis |
title_fullStr |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis |
title_full_unstemmed |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis |
title_sort |
Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis |
author |
Sequetto, Priscila L. |
author_facet |
Sequetto, Priscila L. Gonçalves, Reggiani V. Pinto, Aloísio S. Oliveira, Maria G. A. Maldonado, Izabel R. S. C. Oliveira, Tânia T. Novaes, Rômulo D. |
author_role |
author |
author2 |
Gonçalves, Reggiani V. Pinto, Aloísio S. Oliveira, Maria G. A. Maldonado, Izabel R. S. C. Oliveira, Tânia T. Novaes, Rômulo D. |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Sequetto, Priscila L. Gonçalves, Reggiani V. Pinto, Aloísio S. Oliveira, Maria G. A. Maldonado, Izabel R. S. C. Oliveira, Tânia T. Novaes, Rômulo D. |
dc.subject.por.fl_str_mv |
Bone Glucocorticoid Microanalysis Pathology Scanning electron microscopy |
topic |
Bone Glucocorticoid Microanalysis Pathology Scanning electron microscopy |
description |
By using an experimental model of dexamethasone-induced osteoporosis we investigated the effects of different therapeutic schemes combining sodium alendronate (SA) and simvastatin on bone mineral and protein composition, microstructural and mechanical remodeling. Wistar rats were randomized into eight groups: G1: non-osteoporotic; G2: osteoporotic; G3, G4, and G5: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively); G6, G7, and G8: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively) + simvastatin (0.4, 0.6, and 1 mg/kg, respectively). Osteoporosis was induced by dexamethasone (7 mg/kg, i.m.) once a week for 5 weeks. All treatments were administered for 8 weeks. Dexamethasone increased serum levels of alkaline phosphatase, calcium, phosphorus, and urea, especially in non-treated animals, which showed severe osteoporosis. Dexamethasone also induced bone microstructural fragility and reduced mechanical resistance, which were associated with a marked depletion in mineral mass, collagenous and non-collagenous protein levels in cortical and cancellous bone. Although SA has attenuated osteoporosis severity, the effectiveness of drug therapy was enhanced combining alendronate and simvastatin. The restoration in serum parameters, organic and inorganic bone mass, and mechanical behavior showed a dose-dependent effect that was potentially related to the complementary mechanisms by which each drug acts to induce bone anabolism, accelerating tissue repair. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-10 2018-12-04T12:36:46Z 2018-12-04T12:36:46Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
1435-8115 http://dx.doi.org/10.1017/S1431927617012363 http://www.locus.ufv.br/handle/123456789/22685 |
identifier_str_mv |
1435-8115 |
url |
http://dx.doi.org/10.1017/S1431927617012363 http://www.locus.ufv.br/handle/123456789/22685 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Volume 23, Issue 5, Pages 989- 1001, October 2017 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
pdf application/pdf |
dc.publisher.none.fl_str_mv |
Microscopy and Microanalysis |
publisher.none.fl_str_mv |
Microscopy and Microanalysis |
dc.source.none.fl_str_mv |
reponame:LOCUS Repositório Institucional da UFV instname:Universidade Federal de Viçosa (UFV) instacron:UFV |
instname_str |
Universidade Federal de Viçosa (UFV) |
instacron_str |
UFV |
institution |
UFV |
reponame_str |
LOCUS Repositório Institucional da UFV |
collection |
LOCUS Repositório Institucional da UFV |
repository.name.fl_str_mv |
LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV) |
repository.mail.fl_str_mv |
fabiojreis@ufv.br |
_version_ |
1822610664660664320 |